Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of Macrophage Activation syndromE in STill's Disease: Retrospective Chart Analysis of Patient HistorY, Symptom Resolution and Treatment Characteristics

NCT06405152 is registered in ClinicalTrials.gov with Swedish Orphan Biovitrum as lead sponsor.

NCT NCT06405152
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06405152 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of Macrophage Activation syndromE in STill's Disease: Retrospective Chart Analysis of Patient HistorY, Symptom Resolution and Treatment Characteristics
Lead sponsor
Swedish Orphan Biovitrum
Phase
Observational
Overall status
Completed
Start date
September 27, 2023
Completion date
September 26, 2024
Enrollment
75 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

macrophage activation syndrome, still's disease, adult-onset, stills disease, juvenile-onset